Scarica l'app Stockscreener
1.55
72.42%
0.6511
Dopo l'orario di chiusura:
1.45
-0.10
-6.45%
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
Predicting NovaBay Pharmaceuticals Inc. trend using moving averagesJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Stocks to Watch Today : Nvidia, CrowdStrike, DSS Inc., NovaBay Pharma, Kohl’s Corporation - Eurasia Business News
How to build a custom watchlist for NovaBay Pharmaceuticals Inc.Gold Moves & Smart Swing Trading Techniques - Newser
Top Midday Gainers - MarketScreener
NovaBay’s Dramatic Stock Rise: What’s Next? - StocksToTrade
NovaBay Stock Surge: Buy or Wait? - timothysykes.com
Advanced analytics toolkit walkthrough for NovaBay Pharmaceuticals Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Why Did Novabay Stock Soar 56.84%? - AInvest
Is NovaBay Pharmaceuticals Inc. stock entering bullish territoryAnalyst Downgrade & Safe Capital Preservation Plans - Newser
NovaBay Pharmaceuticals Stock Soars 48% After Hours, Following Special Dividend Declaration - inkl
NovaBay, MongoDB, And Jinxin Pop On News And Results - Finimize
Combining machine learning predictions for NovaBay Pharmaceuticals Inc.Trade Risk Summary & Long-Term Safe Investment Ideas - Newser
Using data tools to time your NovaBay Pharmaceuticals Inc. exitEarnings Recap Report & Fast Entry Momentum Alerts - Newser
Screener Results Flag NovaBay Pharmaceuticals Inc. as Oversold getLinesFromResByArray error: size == 0 - newsyoung.net
NovaBay Pharma Announces Special Cash Dividend - TipRanks
NovaBay's $0.80 Special Dividend: A Strategic Catalyst for Shareholder Value Amid Restructuring - AInvest
NovaBay Pharmaceuticals Declares Special Cash Dividend of $0.80 a Share, Payable Sept. 29 to Holders of Record Sept. 15 - MarketScreener
Novabay Pharmaceuticals announces one-time special cash dividend of $0.80 per share - MarketScreener
Price action breakdown for NovaBay Pharmaceuticals Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
Can technical indicators confirm NovaBay Pharmaceuticals Inc.’s reversal2025 Technical Overview & Safe Swing Trade Setups - Newser
Insider Buy: What’s the MACD signal for NovaBay Pharmaceuticals Inc.July 2025 Momentum & Reliable Breakout Stock Forecasts - sundaytimes.kr
Order flow analysis tools used on NovaBay Pharmaceuticals Inc.Weekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Is now a turning point for NovaBay Pharmaceuticals Inc.July 2025 Recap & AI Based Trade Execution Alerts - Newser
Signal strength of NovaBay Pharmaceuticals Inc. stock in tech scannersJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
What is NovaBay Pharmaceuticals Inc. s debt to equity ratio2025 Historical Comparison & Risk Managed Investment Entry Signals - theviewers.co.kr
Is NovaBay Pharmaceuticals Inc. a turnaround story2025 Stock Rankings & Smart Allocation Stock Tips - theviewers.co.kr
Can NovaBay Pharmaceuticals Inc. rally from current levelsJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
Investor Alert: NBY, OP, STAI, PNPNFStocks Under $1 Complete Watch List Inside - MarketScreener
NovaBay Pharmaceuticals Enters $6M Securities Purchase Agreement, Stock Trades Higher - AInvest
What’s next for NovaBay Pharmaceuticals Inc. stock priceJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
NovaBay Stock Is Trading Higher Wednesday: What's Going On?NovaBay Pharmaceuticals (AMEX:NBY) - Benzinga
Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsEarnings Summary Report & Intraday High Probability Setup Alerts - Newser
Novabay's 67.5% Surge: A Lifeline Investment Ignites Biotech Drama - AInvest
NovaBay’s Rise: Future Growth or Bubble? - StocksToTrade
Novabay Pharmaceuticals, Inc. shares rise over 100.0%, currently trading at $1.23 - AInvest
What Does This Mean for NovaBay Pharmaceuticals? - timothysykes.com
NovaBay Pharmaceuticals Secures $6 Million Investment, Shares Surge - AInvest
NovaBay Names New CEO, Rocket Soars As FDA Lifts Clinical Hold, Celldex Plunges, Soligenix On Watch - RTTNews
NovaBay Pharmaceuticals stock surges 60% after securing $6 million deal with private investor David Lazar, who takes on role of CEO. - AInvest
NovaBay Stock Soars 65.67% on $6M Investment - AInvest
NovaBay Pharmaceuticals Reverses Liquidation Path with $6 Million Investment Deal and Leadership Changes - AInvest
NovaBay Pharma Appoints New CEO Amid Strategic Shift - MSN
NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment - Benzinga
NovaBay Pharmaceuticals shares rise 81.67% premarket after entering a $6 million securities purchase agreement with David E. Lazar. - AInvest
Can volume confirm reversal in NovaBay Pharmaceuticals Inc.Trade Analysis Report & Low Drawdown Investment Strategies - Newser
Historical volatility pattern of NovaBay Pharmaceuticals Inc. visualized2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
NovaBay Pharmaceuticals Secures $6M Investment from David Lazar through Securities Purchase Agreement - AInvest
NovaBay's $6M Lazar Transaction and Strategic Turnaround Potential: A Deep Dive into Capital Restructuring and Shareholder Value Creation in Distressed Biotech Plays - AInvest
NovaBay's Strategic Turnaround: A $6M Lifeline and Leadership Shift Signal New Value Propositions - AInvest
NovaBay jumps after $6 million investment, new CEO - TradingView
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Manila Times
NovaBay Pharmaceuticals enters into $6 million securities purchase agreement with investor David Lazar - MarketScreener
NovaBay Pharmaceuticals Raises $6 Million, Appoints David Lazar CEO. - AInvest
NovaBay Pharmaceuticals Secures $6 Million Investment from David E. Lazar, Appoints New CEO - AInvest
Screener Results Flag NovaBay Pharmaceuticals Inc. as OversoldJuly 2025 Drop Watch & Community Verified Trade Signals - classian.co.kr
When is the best time to buy NovaBay Pharmaceuticals Inc. stockQuarterly Portfolio Review & High Return Trade Guides - Newser
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):